1. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial;Lassman;Neuro Oncol,2022
2. Food and Drug Administration. Multiple endpoints clinical trials guidance for industry. Available at: https://www.federalregister.gov/documents/2022/10/21/2022-22882/multiple-endpoints-in-clinical-trials-guidance-for-industry-availability. Accessed February 6, 2023.
3. Statistical Issues in Drug Development;Senn,2021
4. Moving to a World Beyond “P < 0.05.”;Wasserstein,2019
5. HARKing, cherry-picking, p-hacking, fishing expeditions, and data dredging and mining as questionable research practices;Andrade;J Clin Psychiatry,2021